CONTROL OF PHARMACEUTICALS AND ANIMAL HEALTH PRODUCTS IN WASTEWATER EFFLUENTS FROM MANUFACTURING SITES
Abstract:In many cases, the discharge of pharmaceuticals and animal health products at bulk manufacturing, fill/finish, development and research operations may not be directly regulated with numeric limitations as a part of a facility's wastewater discharge permit. The biological activity of these discharged compounds, if not properly managed, may have the potential to impact the operation of an onsite or a municipal wastewater treatment plant, aquatic species in streams, rivers, oceans, or a drinking water source. An overview of the Eli Lilly and Company environmental protection program is provided, which shows how potential releases of active ingredients from its operations are managed to protect the environment.
Document Type: Research Article
Publication date: January 1, 2005
More about this publication?
- Proceedings of the Water Environment Federation is an archive of papers published in the proceedings of the annual Water Environment Federation® Technical Exhibition and Conference (WEFTEC® ) and specialty conferences held since the year 2000. These proceedings are not peer reviewed. WEF Members: Sign in (right panel) with your IngentaConnect user name and password to receive complimentary access.
- Subscribe to this Title
- Membership Information
- About WEF Proceedings
- WEFTEC Conference Information
- ingentaconnect is not responsible for the content or availability of external websites